Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma-Reference-Cited by-同舟云学术

Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma

Published:2023-09 Issue: Volume:61 Page:101100
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Kegyes David,Gulei Diana,Drula Rares,Cenariu Diana,Tigu Bogdan,Dima Delia,Tanase Alina,Badelita Sorina,Buzoianu Anca-Dana,Ciurea Stefan,Ghiaur Gabriel,Terpos Evangelos,Ciechanover Aaron,Einsele Hermann,Tomuleasa Ciprian

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference209 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Seminar - multiple myeloma;van de Donk NW;The Lancet [Internet],2021

3. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma;Went;Nat Commun,2018

4. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance;Vachon;Blood [Internet],2009

5. Multiple myeloma;Kumar;Nat Rev Dis Primers,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells;Heliyon;2024-06

2. Editorial: Multiple Myeloma: Molecular Mechanism and Targeted Therapy;International Journal of Molecular Sciences;2024-03-28

3. CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells;Cancer Biology & Therapy;2024-02-15

4. LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473;Frontiers in Oncology;2023-09-14